Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Maine Medicaid May Use Medicare To Enhance Price Power: PDP Meets PDL

Executive Summary

State Medicaid agencies are considering ways to use the upcoming Medicare prescription drug coverage program to enhance their drug price negotiating power

You may also be interested in...



Dual-Eligible Switch Poses New Barriers To Drug Access – Consultant

Low-income seniors may face new barriers to obtaining prescription drugs after Medicare assumes responsibility for their coverage, Southeastern Consultants President Mary Kay Owens said at an IIR Medicaid conference in Denver

Dual-Eligible Switch Poses New Barriers To Drug Access – Consultant

Low-income seniors may face new barriers to obtaining prescription drugs after Medicare assumes responsibility for their coverage, Southeastern Consultants President Mary Kay Owens said at an IIR Medicaid conference in Denver

Medicare Rx Plan Negotiations Will Avert Drug Industry “Windfall” – PhRMA

The Pharmaceutical Research & Manufacturers of America disagrees with the prediction that Medicare's assumption of "dual eligibles" will be a financial boon for drug makers

Related Content

UsernamePublicRestriction

Register

PS043496

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel